Skip to main contentSkip to navigation
Sirius Investors
Xeno Transplants Corporation

Xeno Transplants Corporation

XENO
OTC•Healthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for XENO. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Quick links:Overview•Financial Metrics•Technicals•Returns•Financials•Performance

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
39.72M
59.0x increase over period
CAGR: +668.07%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
39.69M
61.5x increase over period
CAGR: +683.99%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Mar 31, 2008

EV/EBITDA

Distorted

-41.20x

Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.

EV vs Market Cap Spread

-32.10K

EV is -0.1% vs equity value

Capital Structure Signal

Net Cash Profile

EV premium trend: +4.0 pp vs earliest data

Additional Multiples

EV/Sales: 0.00x

Net Debt/EBITDA: -4.38x

Share count change in dataset: +412.56%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Jun 30, 200739.72M39.69M$1.2033.18M
Jun 30, 2006953.51K953.48K$0.109.17M
Jun 30, 2005673.28K645.70K$0.106.47M

Enterprise Value Analysis

Price Change (Jun 2006 to Jun 2007)

The stock price has increased from Jun 2006 to Jun 2007.
11.5x increase

Recent Volatility

The stock price has been relatively volatile over the last 3 periods, indicating a higher risk profile.
5.27

Risk-Adjusted Return

The stock's returns do not compensate for its risk level, suggesting a poor risk-reward profile.
1.00

Market Cap Change (Jun 2006 to Jun 2007)

The company's market capitalization has increased from Jun 2006 to Jun 2007.
41.7x increase

Enterprise Value Change (Jun 2006 to Jun 2007)

The company's enterprise value has increased from Jun 2006 to Jun 2007, suggesting growth in the company's total economic value.
41.6x increase

Market Cap vs. Enterprise Value

A lower enterprise value growth rate compared to market cap growth could suggest that the company is reducing debt or increasing cash reserves.
Market Cap Growth > EV Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (3 periods), accounting for compounding effects.
668.07%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (3 periods), accounting for compounding effects.
683.99%